- Investigator
- Parta Hatamizadeh
Clinical trials
Schedule appointment
(352) 265-0751
-
Hospitalized Heart Failure Patients -
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to…
- Investigator
- Alex M Parker
- Ages
- 18 Years - 130 Years
- Sexes
- All
-
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure INVESTED will test the hypothesis that high dose trivalent influenza vaccine will reduce cardiopulmonary events to a greater extent than standard dose quadrivalent influenza vaccine in high-risk cardiovascular patients with a recent history of…
- Investigator
- Carl J Pepine
- Ages
- 18 Years - N/A
- Sexes
- All
-
TEAM-HF The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on…
- Investigator
- Mustafa M Ahmed
- Ages
- 18 Years - N/A
- Sexes
- All
-
GATORSCALES - Investigator
- Mustafa M Ahmed
-
JXR CARD ORTE FINALITY Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients with heart failure and reduced ejection fraction (HFrEF) who are intolerant or ineligible to receive treatment with steroidal mineralocorticoid receptor…
- Ages
- 18 Years - N/A
- Sexes
- All
-
MICROBIOTA HTN Hypertension is the single most prevalent risk factor for heart diseases, heart failure, kidney failure and stroke. About 1 in 3 adults in the United States have hypertension. Approximately 28-30% of hypertensive patients suffer from resistant…
- Investigator
- Carl J Pepine
- Ages
- 18 Years - 80 Years
- Sexes
- All